Online inquiry

IVTScrip™ mRNA-Anti-LAG3, LAG-525(Cap 0, 2-Thio-UTP, 30 nt-poly(A)) (CAT#: GTTS-WQ10133MR)

This product GTTS-WQ10133MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 2-Thio-UTP. It ecodes the monoclonal antibody that targets LAG3 gene. The antibody can be applied in Solid tumors research.

Specifications
Product type	mRNA
Modified bases	2-Thio-UTP
5' Cap	Cap 0
Species	Humanized
RefSeq	NM_002286.6
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	3902
UniProt ID	P18627

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-LAG3, LAG-525(Cap 0, 2-Thio-UTP, 30 nt-poly(A)) (GTTS-WQ10133MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ6952MR	IVTScrip™ mRNA-Anti-VEGFA, ESBA-1008(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	ESBA-1008
GTTS-WQ12608MR	IVTScrip™ mRNA-Anti-F11, NVS250519(Cap 1, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	NVS250519
GTTS-WQ3291MR	IVTScrip™ mRNA-Anti-alpha toxin&<br />lukE, ASN-1(Cap 0, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	ASN-1
GTTS-WQ11265MR	IVTScrip™ mRNA-Anti-CD274, MEDI4736(Cap 0, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	MEDI4736
GTTS-WQ5034MR	IVTScrip™ mRNA-Anti-GLP1R, CA Exendin-4(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	CA Exendin-4
GTTS-WQ8658MR	IVTScrip™ mRNA-Anti-CD38, HuMax-CD38(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	HuMax-CD38
GTTS-WQ523MR	IVTScrip™ mRNA-Anti-CD40, 4D11(Cap 0, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	4D11
GTTS-WQ13531MR	IVTScrip™ mRNA-Anti-MCAM, PRX-003(Cap 0, 5-Methoxy-UTP, 120 nt-poly(A))	mRNA	PRX-003

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST